SGLT2 inhibitors reduce sudden cardiac death risk in heart failure: Meta‐analysis of randomized clinical trials

MLA

Connor P. Oates, et al. “SGLT2 Inhibitors Reduce Sudden Cardiac Death Risk in Heart Failure: Meta‐analysis of Randomized Clinical Trials.” Journal of Cardiovascular Electrophysiology, vol. 34, Mar. 2023, pp. 1277–85. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d9e2a3fbaf0d629e57158958e575496a&authtype=sso&custid=ns315887.

APA

Connor P. Oates, Carlos G. Santos‐Gallego, Alex Smith, Binaya Basyal, Noah Moss, Iwanari Kawamura, Daniel R. Musikantow, Mohit K. Turagam, Marc A. Miller, William Whang, Srinivas R. Dukkipati, Vivek Y. Reddy, & Jacob S. Koruth. (2023). SGLT2 inhibitors reduce sudden cardiac death risk in heart failure: Meta‐analysis of randomized clinical trials. Journal of Cardiovascular Electrophysiology, 34, 1277–1285.

Chicago

Connor P. Oates, Carlos G. Santos‐Gallego, Alex Smith, Binaya Basyal, Noah Moss, Iwanari Kawamura, Daniel R. Musikantow, et al. 2023. “SGLT2 Inhibitors Reduce Sudden Cardiac Death Risk in Heart Failure: Meta‐analysis of Randomized Clinical Trials.” Journal of Cardiovascular Electrophysiology 34 (March): 1277–85. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d9e2a3fbaf0d629e57158958e575496a&authtype=sso&custid=ns315887.